Open AccessAbstract 3119: Treatment prediction by subset analysis of tumor infiltrating lymphocytes (TILs) in combination therapy with trastuzumab, pertuzumab, and docetaxel for advanced HER2-positive breast cancer
Author(s) -
Koji Takada,
Shinichiro Kashiwagi,
Yuka Asano,
Wataru Goto,
Tamami Morisaki,
Shinichi Noda,
Tsutomu Takashima,
Naoyoshi Onoda,
Kosei Hirakawa,
Masaichi Ohira
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3119
Subject(s) - docetaxel , medicine , oncology , breast cancer , regimen , pertuzumab , trastuzumab , tumor infiltrating lymphocytes , anthracycline , taxane , cancer , immunotherapy